To view the entire article, please read here: https://sheridancp.com/news/currier-plastics-appoints-two-new-board-members/

The post Currier Plastics Appoints Two New Board Members appeared first on Currier Plastics.

Acquisitions will Expand Services, Deepen Life Sciences Capabilities
and Establish West Coast Presence

CHICAGO — January 08, 2025—Sheridan Capital Partners (“Sheridan”) today announced that its portfolio company, Currier Plastics (“Currier”), has completed the strategic acquisitions of medical contract manufacturing businesses Springboard Manufacturing (“Springboard”) and MOS Plastics (“MOS”). Both businesses will be fully integrated into Currier. Terms of the transactions were not disclosed.

Springboard, based in Rancho Cordova, California, serves blue chip life sciences customers with contract manufacturing services, including custom-molded precision components, tooling and assembly. Springboard has more than 200 employees operating across two facilities totaling 140,000 square feet, including meaningful Class 8 cleanroom space.

MOS is a San Jose, California-based contract manufacturer, providing custom-molded precision components, tooling and sub-assemblies, primarily to pharmaceutical, medical technology and diagnostic customers. MOS has over 120 employees operating in one facility with 55,000 square feet, featuring Class 8 and Class 7 cleanroom manufacturing and device assembly.

“We are very excited to integrate Springboard and MOS into the Currier business,” said Currier CEO, Andrew McLean. “Our customers will benefit from the addition of significant cleanroom capacity, adjacent services, a West Coast footprint, and strong expertise serving pharmaceutical, medical device and diagnostic customers.”

“The additions of Springboard and MOS will strengthen Currier’s position as a valued partner to a wider array of life sciences customers while also resulting in significant economies of scale,” said Sean Dempsey, Co-founder and Partner at Sheridan. “Completing these acquisitions so early in our ownership period accelerates our value creation plan for Currier while also providing new opportunities for employees and customers of the combined business.”

John Weber, former CEO of Springboard, has joined the Currier Board of Directors as part of the transaction.  In addition, previous Springboard owner, HC Private Investments, has become a material Currier shareholder, demonstrating their conviction in the strength and prospects for the combined companies.

“Both Springboard and MOS will be better positioned to realize their full potential as part of Currier, benefiting from a dedicated sales force that neither business previously had, as well as operational resources that have enabled Currier to earn its strong reputation for quality and service,” added Weber.

The transactions were led by Sean Dempsey, Michael Bernard, Brian McGregor, and Dimitri Kallioras at Sheridan Capital Partners. McDermott Will & Schulte LLP served as legal counsel to Sheridan Capital Partners and Currier. Debt financing was provided by Fidelity. Winston & Strawn LLP served as legal counsel to Springboard and HC Private Investments. MBS Advisors served as financial advisor and Ramsey Law Group served as legal advisor to MOS Plastics.

About Sheridan Capital Partners

Sheridan Capital Partners is a private equity firm focused exclusively on partnering with businesses across the healthcare landscape, including outsourced services, products and manufacturing, providers, and software and technology. Sheridan’s engaged operational approach brings strategic resources and deep industry expertise with the purpose of accelerating growth, building enduring value, and generating strong results. For more information, visit www.sheridancp.com/.

About Currier Plastics

Founded in 1982 and based in Auburn, New York, Currier Plastics is a contract manufacturer primarily serving life sciences customers with custom, precision plastic components in Class 7 and Class 8 cleanrooms, as well as value-added services such as design engineering, material selection, and cleanroom assembly. For more information, visit www.currierplastics.com.

About HC Private Investments

HC Private Investments is a private equity firm focused on making investments in consumer and industrial manufacturing businesses. With a focus on being the first institutional investor in a business, HCPI seeks to partner with business owners, executives, and management teams to identify opportunities to remove impediments to growth, enabling companies to maximize their full value potential. For more information, please visit www.hcprivateinvest.com.

Media Contact

Trevor Blaisdell

TBlaisdell@StantonPRM.com

646-502-3532

The post Sheridan Capital’s Currier Plastics Completes Strategic Acquisitions of Springboard Manufacturing and MOS Plastics appeared first on Currier Plastics.

Healthcare Manufacturing Veteran Andrew McClean Named New CEO

CHICAGO – September 29^th 2025 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Currier Plastics (“Currier” or “the Company”), a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences. The investment reflects Sheridan’s continued evolution as a healthcare investor with expertise in multiple sectors across the healthcare landscape, from outsourced services and medical products to software and technology for providers, payors and pharma. Concurrently with the closing of the investment, the Company announced that Andrew McClean will be the Company’s new CEO, effective September 22, 2025.

Founded in 1982 and based in Auburn, N.Y., Currier has developed an excellent reputation for its technical capabilities and service to blue-chip customers in healthcare and other highly demanding and regulated end-markets. Utilizing advanced custom blow and injection molding, Currier manufacturers tight tolerance custom components in ISO Class 7 and Class 8 cleanrooms. The Company also offers value-added services such as design engineering, material selection, and assembly.

“I am very proud of what our dedicated employees have created at Currier, and we have found a great partner in Sheridan to continue our steadfast commitment to excellence for our customers,” said Currier Founder and CEO, John Currier. “The healthcare expertise Sheridan brings will be invaluable as we look to execute on organic growth initiatives and strategic M&A. In addition, this partnership and the leadership of our incoming CEO Andrew McClean will enable us to continue to invest in the talent and operational resources to continue providing world-class products and services to our growing customer base across multiple end markets.”

“Currier is the result of our multi-year thesis in medical contract manufacturing and we are very excited to be partnering with them at this inflection point in their growth,” said Sean Dempsey, Co-founder and Partner at Sheridan.

New CEO Andrew McClean brings to Currier more than 25 years of leadership experience in the medical device and pharmaceutical industries, where he has a track record of successfully driving growth and increasing profit margins. Prior leadership positions include CEO & President of medical device and pharmaceutical product design and contract manufacturer SteriPack Group, and CEO of Sirtex, a leading manufacturer of minimally invasive interventional oncology solutions. Earlier in his career McClean held a number of senior sales, marketing, and business development roles at global medical technology leader BD (Becton, Dickinson and Company) and Pfizer. “Currier’s excellent reputation for quality, technical capabilities and customer service have been established over decades. I look forward to continuing and growing this legacy,”  said McLean.

“Currier continues to win new business from highly demanding customers for a reason. We are excited to add even more resources to Currier so it can be the best possible partner to its customers,” added Sheridan Principal, Michael Bernard.

The transaction was led by Sean Dempsey, Michael Bernard, Brian McGregor, and Dimitri Kallioras at Sheridan Capital Partners. McDermott Will & Schulte LLP served as legal counsel and William Blair served as financial advisor to Sheridan Capital Partners. Stout Capital served as financial advisor and Benesch, Friedlander, Coplan & Aronoff LLP served as legal advisor to Currier. Financial terms of the transaction were not disclosed.

About Sheridan Capital Partners

Sheridan Capital Partners is a healthcare private equity firm that focuses on lower middle market buyouts and growth equity in the U.S. and Canada. Sheridan partners with companies in the verticals of providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, and strives to bring strategic resources to accelerate growth, build enduring value, and achieve strong results. For more information, please visit www.sheridancp.com/.

About Currier Plastics

Founded in 1982 and based in Auburn, New York, Currier Plastics is a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences. Utilizing advanced custom blow and injection molding, Currier manufacturers tight tolerance custom components in ISO Class 7 and Class 8 cleanrooms. The Company also offers value-added services such as design engineering, material selection, and assembly. For more information, visit www.currierplastics.com .

Media Contact

Trevor Blaisdell

TBlaisdell@StantonPRM.com

646-502-3532

The post Sheridan Capital Partners Invests in Currier Plastics appeared first on Currier Plastics.